Case Study: Top 10 Biopharmaceutical Company achieves faster, paperless validation with Kneat Solutions

Top 10 Global Pharmaceutical & Healthcare Company Delivers on Digital Future With Kneat

A top 10 global biopharmaceutical company sought to advance its digital strategy by moving to paperless manufacturing plants. Prior to implementing Kneat, the company used a hybrid of paper and digital solutions for its Commissioning and Qualification (CQV) and Analytical Instrument Qualification (AIQ) processes. Their challenges included a lack of standardization, poor visibility across systems, and the high operational costs associated with paper-based validation.

Kneat provided a flexible, cloud-based digital validation solution that was deployed as a pilot and then scaled across the organization. The implementation by Kneat led to significant efficiency gains, including a 40% reduction in protocol review and approval time and a 12% reduction in protocol development time. The customer also reported substantial work and calendar hour savings across various validation activities, enabling better data integrity and providing a foundation for future AI and machine learning applications.